Advances and Controversies in the Diagnosis and Management of Medullary Thyroid Carcinoma
- 1 July 1997
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 103 (1) , 60-69
- https://doi.org/10.1016/s0002-9343(97)00024-7
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levelsSurgery, 1996
- RET Gene and Its Implications for CancerJNCI Journal of the National Cancer Institute, 1995
- Medullary Thyroid Carcinoma: Recent Advances and Management UpdateThyroid®, 1995
- The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre studyJournal of Internal Medicine, 1995
- Clinical use of molecular information in the management of multiple endocrine neoplasia type 2AJournal of Internal Medicine, 1995
- Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analoguesSeminars in Nuclear Medicine, 1995
- RET proto-oncogene mutations in French MEN 2A and FMTC familiesHuman Molecular Genetics, 1994
- Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 casesClinical Endocrinology, 1993
- Medullary Thyroid CarcinomaThe Endocrinologist, 1992
- New Radionuclide Tracers for the Diagnosis and Therapy of Medullary Thyroid CarcinomaClinical Nuclear Medicine, 1988